v3.26.1
Pay vs Performance Disclosure
 12 Months Ended
Dec. 31, 2025
Pay vs Performance Disclosure  
Pension Benefits Adjustments, Footnote

Pension Plan Benefits

The Company does not have a pension plan in place and therefore no pension plan benefit awards were made to a director or named executive officer during the financial year ended December 31, 2025
Equity Awards Adjustments, Footnote

Outstanding Equity Awards at Fiscal Year-End

The following table sets forth certain information concerning equity awards granted to our named executive officers that remained outstanding as of December 31, 2025.

  Option awards Stock awards
Name Number of
Securities
Underlying
Unexercised
Options
Exercisable
(#)(1)		 Number of
Securities
Underlying
Unexercised
Options
Unexercisable
(#)		 Option
Exercise
Price ($)		 Option
Expiration
Date		 Number of
shares or
units of
stock that
have not
vested (#)		 Market
value of
shares of
units of
stock that
have not
vested ($)		 Equity
incentive
plan
awards:
Number of
unearned
shares,
units or
other
rights that
have not
vested (#)		 Equity
incentive plan
awards:
Market or
payout value of
unearned
shares, units or
other rights
that have not
vested ($)
Dr. Raza Bokhari 250,000 - 0.87 10/24/2028 - - - -
  50,000
 		   2.75 12/17/2029 - - - -
  -
 		 250,000 3.08 07/22/2030 - - - -
   
 		 125,000 1.80 12/16/2030 - - - -
Carolyn Bonner 62,500 - 0.87 10/24/2028 - - - -
  10,000
 		 - 2.75 12/17/2029 - - - -
  -
 		 50,000 3.08 12/17/2029 - - - -
  -  75,000
 		  1.80  12/16/2030 - - - -
Dr. Faisal Mehmud 100,000 -
 		 2.26 11/14/2029 - - - -
  -
 		 50,000
 		 3.08 7/22/2030 - - - -
  -
 		 75,000 1.80 12/16/2030        
Dr. Edward Brennan 75,000 - 0.87 10/24/2028 - - - -
  20,000
 		 -
 		 2.75 12/17/2029 - - - -
  -
 		 50,000 3.08 7/22/2030 - - - -
  -
 		 50,000 1.80 12/16/2030 - - - -
 

Notes:

(1) All options have vested and are currently exercisable as of the date of this Amendment No. 1.